ATE334192T1 - Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide - Google Patents

Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide

Info

Publication number
ATE334192T1
ATE334192T1 AT00916131T AT00916131T ATE334192T1 AT E334192 T1 ATE334192 T1 AT E334192T1 AT 00916131 T AT00916131 T AT 00916131T AT 00916131 T AT00916131 T AT 00916131T AT E334192 T1 ATE334192 T1 AT E334192T1
Authority
AT
Austria
Prior art keywords
cells
polypeptides
antibodies
isolation
corresponding hybridoma
Prior art date
Application number
AT00916131T
Other languages
English (en)
Inventor
Didier Leturcq
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE334192T1 publication Critical patent/ATE334192T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT00916131T 1999-03-12 2000-03-08 Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide ATE334192T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12425399P 1999-03-12 1999-03-12

Publications (1)

Publication Number Publication Date
ATE334192T1 true ATE334192T1 (de) 2006-08-15

Family

ID=22413749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00916131T ATE334192T1 (de) 1999-03-12 2000-03-08 Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide

Country Status (8)

Country Link
EP (1) EP1161522B1 (de)
JP (1) JP4712194B2 (de)
AT (1) ATE334192T1 (de)
AU (1) AU3728400A (de)
CA (1) CA2365639C (de)
DE (1) DE60029570T2 (de)
DK (1) DK1161522T3 (de)
WO (1) WO2000055305A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090153A2 (en) * 2000-05-23 2001-11-29 Nexell Therapeutics, Inc. Reagents for cell selection and methods of use
WO2019032661A1 (en) * 2017-08-09 2019-02-14 Orionis Biosciences Inc. CD8 LIAISON AGENTS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006459A (en) * 1986-03-31 1991-04-09 T Cell Sciences, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
US5645837A (en) * 1995-01-17 1997-07-08 Thomas Jefferson University Peptides that inhibit T cell activation and methods of using the same
US6001962A (en) * 1996-11-15 1999-12-14 The Regents Of The University Of California Modified Fas ligands
WO1999054345A1 (en) * 1998-04-21 1999-10-28 Thomas Jefferson University Cd8 antagonists

Also Published As

Publication number Publication date
DE60029570D1 (de) 2006-09-07
AU3728400A (en) 2000-10-04
JP4712194B2 (ja) 2011-06-29
DK1161522T3 (da) 2006-12-04
EP1161522B1 (de) 2006-07-26
CA2365639C (en) 2013-05-14
WO2000055305A1 (en) 2000-09-21
JP2003526332A (ja) 2003-09-09
DE60029570T2 (de) 2007-08-16
CA2365639A1 (en) 2000-09-21
EP1161522A1 (de) 2001-12-12

Similar Documents

Publication Publication Date Title
ES2121400T3 (es) Seleccion celular positiva y positiva/negativa mediada por liberacion con peptidos.
DE69230146D1 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
IS2508B (is) Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir
EP2186884A3 (de) Monoklonale Antikörpergegen HCV Kernantigen
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
IL148113A0 (en) Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
ATE284900T1 (de) Spezifische antikörper für dendritische zellen
EP1433792A8 (de) Menschlische-rezeptor Proteine; verwandte Reagenzien und Methoden
ATE279443T1 (de) A3c6e2, ein monoklonaler antikörper spezifisch für den humanen stammzellfaktor (scf)-rezeptor
WO2001036467A3 (en) Mammalian receptor proteins; related reagents and methods
GB9318612D0 (en) An assay
AU2003283240A1 (en) Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
ATE334192T1 (de) Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
WO2005065711A3 (en) Mammalian receptor proteins; related reagents and methods
DK1171157T3 (da) Anvendelse af glucose-6-phosphat-isomerase og antistoffer derimod til diagnosticering og behandling af arthritis, og test for anti-arthritis-forbindelser
GR3029320T3 (en) Monoclonal antibodies to putative hcv ns5 proteins and methos for using same.
WO1999019480A3 (en) Human receptor proteins; related reagents and methods
WO2024102935A3 (en) Antigen-binding domains and methods of use thereof
BR0204612A (pt) Anticorpos monoclonais antinúcleo de hcv
SE9900875D0 (sv) Antinuclear antibody assay utilizing stress-treated cells or cell extracts
NZ335545A (en) Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56
AR037216A1 (es) Anticuerpos monoclonales antinucleares de hcv
WO2001046419A3 (en) Mammalian prion proteins; related reagents and methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161522

Country of ref document: EP